🇺🇸 FDA
Pipeline program

mRNA-1010

mRNA-1010-P301

Phase 3 mab completed

Quick answer

mRNA-1010 for Seasonal Influenza is a Phase 3 program (mab) at Moderna Biotech Spain with 1 ClinicalTrials.gov record(s).

Program details

Company
Moderna Biotech Spain
Indication
Seasonal Influenza
Phase
Phase 3
Modality
mab
Status
completed

Clinical trials